Prognostic significance of TPX2 and NIBP in esophageal cancer

Sui,Chao; Song,Zhifang; Yu,Huimin; Wang,Haiwen

doi:10.3892/ol.2019.10747

Prognostic significance of TPX2 and NIBP in esophageal cancer

Authors:
- Chao Sui
- Zhifang Song
- Huimin Yu
- Haiwen Wang
View Affiliations

Affiliations: Department of Medical Oncology, Weihai Central Hospital, Weihai, Shandong 264400, P.R. China, Department of Oncology, Weihai Central Hospital, Weihai, Shandong 264400, P.R. China, Department of Thoracic Surgery, Weihai Central Hospital, Weihai, Shandong 264400, P.R. China
Published online on: August 16, 2019 https://doi.org/10.3892/ol.2019.10747
Pages: 4221-4229

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The expression of targeting protein for Xenopus kinesin‑like protein 2 (TPX2) and NIK‑IKK‑β binding protein (NIBP) in patients with esophageal cancer were investigated. A total of 250 samples of cancer tissue and 250 samples of adjacent normal tissue were collected from 250 patients who underwent radical resection of esophageal cancer in Weihai Central Hospital from March 2011 to February 2014. RT‑qPCR was used to detect the relative expression of TPX2 and NIBP. The relative expression of TPX2 and NIBP in esophageal cancer tissues was statistically higher than those in adjacent normal tissues (P<0.05). TPX2 and NIBP levels in tumor tissues with lymph node metastasis were significantly higher than those in tissues without lymph node metastasis (P<0.05). There was a significant difference in the relative expression of TPX2 and NIBP in different degrees of infiltration (P<0.05). Tissues with a TPX2 level equal to or higher than the average TPX2 level (1.465) were divided into TPX2 high expression group, while tissues with a TPX2 level below the average were divided into TPX2 low expression group. The 5‑year overall survival rate of TPX2 high expression group was significantly lower than that of TPX2 low expression group (P<0.05). Tissues with a NIBP level equal to or higher than the average NIBP level (0.498) were included in the NIBP high expression group, while tissues with a NIBP level below the average were included in the NIBP low expression group. The 5‑year overall survival rate of NIBP high expression group was significantly lower than that of NIBP low expression group (P<0.05). TPX2, NIBP, TNM staging, lymph node metastasis, and degree of infiltration were independent prognostic factors affecting overall survival (P<0.05). In conclusion, owing to their high expression in esophageal cancer tissues, TPX2 and NIBP are potentially important biomarkers for the evaluation of TNM stage, metastasis, and prognosis of esophageal cancer.

View Figures

View References

1	Arnold M, Laversanne M, Brown LM, Devesa SS and Bray F: Predicting the future burden of esophageal cancer by histological subtype: International trends in incidence up to 2030. Am J Gastroenterol. 112:1247–1255. 2017. View Article : Google Scholar : PubMed/NCBI
2	Mao A: Interventional therapy of esophageal cancer. Gastrointest Tumors. 3:59–68. 2016. View Article : Google Scholar : PubMed/NCBI
3	Sunpaweravong S, Ruangsin S, Laohawiriyakamol S, Mahattanobon S and Geater A: Prediction of major postoperative complications and survival for locally advanced esophageal carcinoma patients. Asian J Surg. 35:104–109. 2012. View Article : Google Scholar : PubMed/NCBI
4	Schneider MA, Christopoulos P, Muley T, Warth A, Klingmueller U, Thomas M, Herth FJ, Dienemann H, Mueller NS, Theis F and Meister M: AURKA, DLGAP5, TPX2, KIF11 and CKAP5: Five specific mitosis-associated genes correlate with poor prognosis for non-small cell lung cancer patients. Int J Oncol. 50:365–372. 2017. View Article : Google Scholar : PubMed/NCBI
5	Zhang H, Zhang T, You Z and Zhang Y: Positive surgical margin, HPV persistence, and expression of both TPX2 and PD-L1 are associated with persistence/recurrence of cervical intraepithelial neoplasia after cervical conization. PLoS One. 10:e01428682015. View Article : Google Scholar : PubMed/NCBI
6	Zhao X, Sun S, Zeng X and Cui L: Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma. Am J Cancer Res. 8:450–461. 2018.PubMed/NCBI
7	Chang H, Wang J, Tian Y, Xu J, Gou X and Cheng J: The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer. Oncol Rep. 27:1353–1359. 2012.PubMed/NCBI
8	Jiang T, Sui D, You D, Yao S, Zhang L, Wang Y, Zhao J and Zhang Y: MiR-29a-5p inhibits proliferation and invasion and induces apoptosis in endometrial carcinoma via targeting TPX2. Cell Cycle. 17:1268–1278. 2018. View Article : Google Scholar : PubMed/NCBI
9	Xu CY, Qin MB, Tan L, Liu SQ and Huang JA: NIBP impacts on the expression of E-cadherin, CD44 and vimentin in colon cancer via the NF-κB pathway. Mol Med Rep. 13:5379–5385. 2016. View Article : Google Scholar : PubMed/NCBI
10	Fu ZH, Liu SQ, Qin MB, Huang JA, Xu CY, Wu WH, Zhu LY, Qin N and Lai MY: NIK and IKKβ binding protein contributes to gastric cancer chemoresistance by promoting epithelial mesenchymal transition through the NFκB signaling pathway. Oncol Rep. 39:2721–2730. 2018.PubMed/NCBI
11	Cheng C, Zhou Y, Li H, Xiong T, Li S, Bi Y, Kong P, Wang F, Cui H, Li Y, et al: Whole-genome sequencing reveals diverse models of structural variations in esophageal squamous cell carcinoma. Am J Hum Genet. 98:256–274. 2016. View Article : Google Scholar : PubMed/NCBI
12	Zhang Y, Liu S, Wang H, Yang W, Li F, Yang F, Yu D, Ramsey FV, Tuszyski GP and Hu W: Elevated NIBP/TRAPPC9 mediates tumorigenesis of cancer cells through NFκB signaling. Oncotarget. 6:6160–6178. 2015.PubMed/NCBI
13	Phillips WA, Russell SE, Ciavarella ML, Choong DY, Montgomery KG, Smith K, Pearson RB, Thomas RJ and Campbell IG: Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus. Int J Cancer. 118:2644–2646. 2006. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
15	Cao HH, Zhang SY, Shen JH, Wu ZY, Wu JY, Wang SH, Li EM and Xu LY: A three-protein signature and clinical outcome in esophageal squamous cell carcinoma. Oncotarget. 6:5435–5448. 2015. View Article : Google Scholar : PubMed/NCBI
16	Davis JN, Medbery C, Sharma S, Pablo J, Kimsey F, Perry D, Muacevic A and Mahadevan A: Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(^®) patient registry. Radiat Oncol. 10:1132015. View Article : Google Scholar : PubMed/NCBI
17	Yodying H, Matsuda A, Miyashita M, Matsumoto S, Sakurazawa N, Yamada M and Uchida E: Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: A systematic review and meta-analysis. Ann Surg Oncol. 23:646–654. 2016. View Article : Google Scholar : PubMed/NCBI
18	Choi YL, Takeuchi K, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Hamada T, Haruta H, Watanabe H, et al: Identification of novel isoforms of the EML4-ALK transforming gene in non-small cell lung cancer. Cancer Res. 68:4971–4976. 2008. View Article : Google Scholar : PubMed/NCBI
19	Wang J, Liu Z, Dou C, Han S, Li C, Tu K and Yang W: miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 32:512–517. 2016.(In Chinese). PubMed/NCBI
20	Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, Nakamura K, Yamanaka T, Uchiyama A, Tanaka M and Katano M: Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res. 7:4136–4142. 2001.PubMed/NCBI
21	Hsu PK, Chen HY, Yeh YC, Yen CC, Wu YC, Hsu CP, Hsu WH and Chou TY: TPX2 expression is associated with cell proliferation and patient outcome in esophageal squamous cell carcinoma. J Gastroenterol. 49:1231–1240. 2014. View Article : Google Scholar : PubMed/NCBI
22	Liu HC, Zhang Y, Wang XL, Qin WS, Liu YH, Zhang L and Zhu CL: Upregulation of the TPX2 gene is associated with enhanced tumor malignance of esophageal squamous cell carcinoma. Biomed Pharmacother. 67:751–755. 2013. View Article : Google Scholar : PubMed/NCBI
23	Liu HC, Zhang GH, Liu YH, Wang P, Ma JF, Su LS, Li SL, Zhang L and Liu JW: TPX2 siRNA regulates growth and invasion of esophageal cancer cells. Biomed Pharmacother. 68:833–839. 2014. View Article : Google Scholar : PubMed/NCBI
24	Pazarentzos E and Bivona TG: Adaptive stress signaling in targeted cancer therapy resistance. Oncogene. 34:5599–5606. 2015. View Article : Google Scholar : PubMed/NCBI
25	Qin M and Liu S, Li A, Xu C, Tan L, Huang J and Liu S: NIK- and IKKβ-binding protein promotes colon cancer metastasis by activating the classical NF-κB pathway and MMPs. Tumour Biol. 37:5979–5990. 2016. View Article : Google Scholar : PubMed/NCBI